Jump to Content

All news & insights

Published in Wound Repair and Regeneration—Safety of up to 140 Daily Applications of Recombinant Human Platelet‐Derived Growth Factor (rhPDGF‐BB) Onto Skin Wounds: Unboxing the Evidence

Slade HB, Lynch SE, Dickerson Jr JE

Published on January 16, 2026

Wound Repair Regen. 2025 Nov 11;33(6):e70108. doi: 10.1111/wrr.70108

DISCLAIMER: The accompanying article discusses approved and unapproved uses of recombinant human Platelet-Derived Growth Factor-BB (rhPDGF-BB or PDGF). Unapproved uses of PDGF have not been approved by the FDA, and the safety and effectiveness of PDGF for such unapproved uses have not been established. The article is provided for informational and scientific discussion purposes only and does not constitute promotion of any unapproved product or use.

View the article

Safety of up to 140 Daily Applications of Recombinant Human Platelet‐Derived Growth Factor (rhPDGF‐BB) Onto Skin Wounds: Unboxing the Evidence
Lynch Regenerative Medicine
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.